Schrodinger Inc (43Z.MU)

Compare

15.75

-1.38

(-8.06%)

At close: April 4 at 2:40:54 PM GMT+2

Schrödinger (NASDAQ:SDGR) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Simply Wall St. 9 days ago

SDGR
Schrödinger to Present Preclinical Data at AACR Annual Meeting

NEW YORK, March 25, 2025--Schrödinger today announced that new preclinical data on SGR-3515 and SGR-4174 will be presented at the AACR Annual Meeting 2025.

Business Wire 10 days ago

SDGR
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, March 18, 2025--Schrödinger, Inc. (Nasdaq: SDGR) today reported that on March 15, 2025, the company granted (i) a non-statutory stock option to purchase 1,575 shares of the company’s common stock to one newly hired employee and (ii) restricted stock units (RSUs) with respect to 6,943 shares of the company’s common stock to seven newly hired employees. These grants were made pursuant to the company’s 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of t

Business Wire 18 days ago

SDGR
Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

NEW YORK, March 10, 2025--Schrödinger, Inc. today announced the appointment of Bridget van Kralingen to its Board of Directors, effective March 7, 2025.

Business Wire 26 days ago

SDGR
Schrödinger Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Schrödinger ( NASDAQ:SDGR ) Full Year 2024 Results Key Financial Results Revenue: US$207.5m (down 4.2% from FY 2023...

Simply Wall St. last month

SDGR
Q4 2024 Schrodinger Inc Earnings Call

Q4 2024 Schrodinger Inc Earnings Call

Thomson Reuters StreetEvents last month

NVS

SDGR
Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

Despite a decline in total revenue, Schrodinger Inc (SDGR) showcases robust software performance and strategic collaborations for future growth.

GuruFocus.com last month

SDGR

NVS
Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates

Schrodinger (SDGR) delivered earnings and revenue surprises of -57.14% and 5.79%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks last month

SDGR
Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

NEW YORK, February 26, 2025--Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Business Wire last month

SDGR
Schrödinger to Participate in Upcoming Investor Conferences

NEW YORK, February 24, 2025--Schrödinger (Nasdaq: SDGR) today announced that management will participate in the following conferences in March:

Business Wire last month

SDGR
Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today

Xpeng (XPEV) and Schrodinger (SDGR) are climbing 5% and 3.3%, respectively, today after Nasdaq.com reported that institutions had acquired many more shares in the companies than they had sold in recent quarters. Additionally, a number of institutions raised their stakes in XPEV and SDGR by large amounts in Q4. China-based XPEV is an EV maker […]

Insider Monkey last month

XPEV

SDGR
Schrodinger Stock Scores IBD Rating Upgrade

Schrodinger shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investor's Business Daily last month

CSBR

NTRA

SDGR
Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

NEW YORK, February 12, 2025--Schrödinger will report its fourth quarter and full-year 2024 financial results on Wednesday, February 26, 2025, after the financial markets close.

Business Wire last month

SDGR
Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss

It is doubtless a positive to see that the Schrödinger, Inc. ( NASDAQ:SDGR ) share price has gained some 41% in the...

Simply Wall St. 2 months ago

SDGR
Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI

We recently published a list of 10 AI News And Ratings on Wall Street’s Radar. In this article, we are going to take a look at where Schrödinger, Inc. (NASDAQ:SDGR) stands against other AI news and ratings on Wall Street’s radar. The launch of China’s DeepSeek AI app is prompting investors to question top AI […]

Insider Monkey 2 months ago

SDGR
Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a look at where Schrödinger, Inc. (NASDAQ:SDGR) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up sharply since the COVID-19 pandemic. With the advent of […]

Insider Monkey 2 months ago

SDGR
Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Schrödinger, Inc. (NASDAQ:SDGR) stands against the other stocks that are skyrocketing now. The market has started to favor smaller companies in 2025, and stocks between $1 billion and $5 […]

Insider Monkey 2 months ago

SDGR
Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Schrodinger (SDGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Zacks 2 months ago

SDGR

FLGT
Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today. The rally comes after an Alphabet (GOOG,GOOGL) executive yesterday reported that the firm intends to start testing its AI-developed drugs this year. Schrodinger (SDGR) and Recursion Pharmaceuticals (RXRX), which both specialize in using AI to hasten drug discovery, […]

Insider Monkey 2 months ago

GOOG

SDGR
Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

NEW YORK, January 13, 2025--Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025.

Business Wire 2 months ago

SDGR

Performance Overview

Return	43Z.MU	S&P 500 (^GSPC)
YTD	-17.71%	-13.73%
1-Year	-34.29%	-1.42%
3-Year	-62.05%	+10.72%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Schrodinger Inc (43Z.MU)

Schrödinger (NASDAQ:SDGR) Is In A Good Position To Deliver On Growth Plans

Schrödinger to Present Preclinical Data at AACR Annual Meeting

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Schrödinger Expands Board of Directors with Appointment of Bridget van Kralingen

Schrödinger Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Q4 2024 Schrodinger Inc Earnings Call

Schrodinger Inc (SDGR) Q4 2024 Earnings Call Highlights: Strong Software Growth Amidst Revenue ...

Schrodinger, Inc. (SDGR) Reports Q4 Loss, Tops Revenue Estimates

Schrödinger Reports Strong Fourth Quarter and Full-Year 2024 Financial Results

Schrödinger to Participate in Upcoming Investor Conferences

Why Xpeng (XPEV) and Schrodinger (SDGR) Are Advancing Today

Schrodinger Stock Scores IBD Rating Upgrade

Schrödinger to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26

Strong week for Schrödinger (NASDAQ:SDGR) shareholders doesn't alleviate pain of five-year loss

Schrödinger (SDGR): Revolutionizing Biopharma with Quantum Mechanics and AI

Schrödinger, Inc. (SDGR): Quantum Mechanics Meets AI in Biopharma, Backed by Hunterbrook’s ‘Key AI Winner’ Endorsement

Why Schrödinger, Inc. (SDGR) Is Skyrocketing Now

Schrodinger (SDGR) Moves 14.1% Higher: Will This Strength Last?

Why Drug Developers That Utilize AI, Including SDGR and RXRX, Are Jumping

Schrödinger Provides Update on Progress Across the Business and Outlines 2025 Strategic Priorities

Performance Overview